Oversight of Right-to-Try and Expanded Access Requests for Off-Trial Access to Investigational Drugs
{{output}}
For decades, the U.S. Food and Drug Administration (FDA) has provided an "expanded access" pathway that allows patients who meet qualifying conditions to gain access outside a clinical trial to an investigational medical product being tested to see if it is sa... ...
